Tilray Brands (TLRY) Total Debt (2017 - 2026)
Tilray Brands' (TLRY) quarterly Total Debt came in at $138.6 million in Q2 2026, down 15.23% YoY from $163.5 million in Q2 2025, and down 9.09% on a QoQ basis from $152.4 million in Q1 2026.
Tilray Brands (TLRY) Total Debt (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Total Debt data on file, last reported at $138.6 million in Q2 2026.
- Quarterly Total Debt fell 15.23% year-over-year to $138.6 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $138.6 million (down 15.23% YoY) and the FY2026 annual result came in at $138.6 million, down 15.23% from the prior year.
- Total Debt fell to $138.6 million in Q2 2026, from $152.4 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $404.0 million in Q3 2023 to a low of $138.6 million in Q2 2026.
- A 5-year average of $218.3 million and a median of $178.4 million in 2022 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2023 — Total Debt jumped 126.46% — and 2024, when it slumped 57.08%.
- Tracing TLRY's Total Debt over 5 years: stood at $333.7 million in 2022, then dropped by 10.84% to $297.5 million in 2023, then sank by 43.99% to $166.6 million in 2024, then declined by 6.6% to $155.6 million in 2025, then slipped by 10.95% to $138.6 million in 2026.
- The last three Total Debt figures came in at $138.6 million (Q2 2026), $152.4 million (Q1 2026), and $155.6 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 760.00 Mn |
| 10 | Tilray Brands | 513.87 Mn | 279.24 Mn | 90.52 Mn | 138.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 138.59 Mn |
| Feb 28, 2026 | 152.44 Mn |
| Nov 30, 2025 | 155.63 Mn |
| Aug 31, 2025 | 160.47 Mn |
| May 31, 2025 | 163.49 Mn |
| Nov 30, 2024 | 166.62 Mn |
| Aug 31, 2024 | 173.40 Mn |
| May 31, 2024 | 176.39 Mn |
| Feb 29, 2024 | 249.00 Mn |
| Nov 30, 2023 | 297.50 Mn |
| Aug 31, 2023 | 403.98 Mn |
| May 31, 2023 | 311.27 Mn |
| Feb 28, 2023 | 273.50 Mn |
| Nov 30, 2022 | 333.66 Mn |
| Aug 31, 2022 | 178.39 Mn |
| May 31, 2022 | 185.70 Mn |
| Feb 28, 2022 | 191.39 Mn |
| Nov 30, 2021 | 214.16 Mn |
| Aug 31, 2021 | 226.41 Mn |
| May 31, 2021 | 228.14 Mn |